PharmaBoardroom

EFPIA’s Nathalie Moll on COVID-19 & the Future of…

In a recent exclusive conversation with PharmaBoardroom, Nathalie Moll, director general of the European Federation of Pharmaceutical Industries &…

New CEO for Ipsen as David Loew Makes Switch From Sanofi Pasteur

David Loew, formerly executive vice president of Sanofi Pasteur, Sanofi's vaccines division, was appointed CEO of fellow French firm Ipsen on the 28th…

Geert Van Hoof – General Manager, Chiesi Belgium

Geert Van Hoof, founding general manager of Chiesi Belgium, shares the exciting milestones of the company’s first decade in Belgium, including their…

Company Spotlight: JLABS @ Shanghai

Johnson & Johnson’s network of healthcare innovation incubators, JLABS, opened its doors in Shanghai in June 2019 and now stands as the largest…

European Pharma Mid-Caps’ US Strategies: Complexity, Scale,…

Three US country managers for European pharma mid-caps explain the challenges in setting up an American affiliate, as well as how best to capitalise…

Albert Yu – Chairman, Hong Kong Biotechnology Organization…

Dr Albert Yu, chairman of the Hong Kong Biotechnology Organization (HKBIO) gives his expert insights into the crucial importance of diagnostics in…

Constanza Losada – President & CEO, Pfizer Mexico

Recently appointed CEO and president for Pfizer Mexico, Constanza Losada, outlines the exciting challenge of taking on leadership for such an…

Sofia Lahlou – Country Manager, Versalya, Morocco

Sofia Lahlou, country manager for women’s and children’s health specialist Versalya in the Moroccan market, discusses the company’s formation,…

Pierre A Morgon – SVP International Business, CanSino…

Pierre A Morgon, SVP International Business for CanSino Biotechnology (CanSinoBIO) – a Chinese vaccine biotech developing one of the frontrunner…

Peking University’s Potential COVID-19 Cure

Highly potent neutralizing antibodies may be the key to laying a foundation for COVID-19 treatment, according to a Chinese research team led by Peking…

Pfizer’s COVID-19 Vaccine: A Unique Approach

At the 28 May 2020 IFPMA media briefing on COVID-19 vaccines, Pfizer chairman and CEO Dr Albert Bourla outlined why the US firm had decided to take a…

Putting People Ahead of the Maths: Addressing the Limitations of…

Mike Glover, Vice President Global Head of Access and Pricing Strategy Oncology at GSK outlines that while new mathematical approaches to health…

Tagged with